XtalPi Holdings Ltd
2228.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.06B
Close$
Share Statistics
| Market cap | $30.06 Billion |
|---|---|
| Enterprise Value | $30.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.03 |
| Beta | 1.32 |
| Outstanding Shares | 4,083,861,000 |
Return
| Return on Equity | -4.50% |
|---|---|
| Return on Assets | -3.21% |
| Return on Invested Capital | -6.98% |
Valuation & Multiples
| P/E Ratio | -115.46 |
|---|---|
| PEG | 28.86 |
| Price to Sales | - |
| Price to Book Ratio | 3.49 |
| Enterprise Value to Revenue | 22.63 |
| Enterprise Value to EBIT | -46.28 |
| Enterprise Value to Net Income | -76 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About XtalPi Holdings Ltd
1,254 employees
CEO: Jian Ma XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its c...